To develop selective measurement techniques for diagnostics, drug research, and the detection of poisons, researchers would like to combine the high specificity of biochemical reactors with universal microelectronics.
Now, researchers at the Max Planck Institute for Biochemistry in Martinsried/Munich have shown that such bioelectronic hybrid systems are no longer just a utopian vision. In the journal Angewandte Chemie, they describe the coupling of a receptor to a silicon chip by means of a cell–transistor interface.
Many receptors are coupled to ion channels within cell membranes. When the corresponding ligand binds to its receptor, the channel is opened, allowing ions to stream into the cell. With a few tiny electrodes (the patch-clamp technique), this stream of ions can be measured; however, this technique destroys the cell. A team headed by Peter Fromherz has now proven that things can be different. Their novel, noninvasive sensor involves coupling of the ion stream directly to a microelectronic device by means of a direct cell–chip contact.
Their test subject was the serotonin receptor, a protein that resides in the membrane and plays an important role in the nervous system. Blockers specific to this receptor are used clinically to reduce the nausea that results from chemotherapy and for the treatment of irritable bowl syndrome. The scientists allowed cells with many serotonin receptors in their membranes to grow onto a silicon chip with a linear arrangement of many transistor switches.
For measurement, a cell that covers the tiny gap (gate) of one of the transistors must be selected. The voltage in this cell is controlled with a special electrode. If serotonin is then applied, the ion channels open; a stream of ions flows along a narrow gap between the cell and the chip into the cell. The resulting signal in the transistor voltage is proportional to the current across the membrane.
By using a variety of serotonin concentrations, a dosage–effect relationship can be determined. The application of new potential receptor blockers allows their effectiveness to be quickly and easily evaluated by means of their effect on the transistor signal. “With this coupling of a ligand-steered ion channel to a transistor at the level of an individual cell,” Fromherz says, “we have laid the foundation for receptor-cell–transistor biosensor technology.”
Source: John Wiley & Sons
Related stories:
Probing Question: Fishhooks of addiction
When the American writer Theodore Roethke taught at Penn State from 1936 to 1943, he was known for three things: being a good poet, coaching the men’s tennis team, and falling down drunk, perhaps the latter more than the former. Roethke, a brilliant and tortured man, knew well the seduction of drink and the agony of addiction. In his poem “Journey Into the Interior,” Roethke writes, “In the long journey out of the self, / There are many detours, washed-out interrupted raw places / Where the shale slides dangerously / And the back wheels hang almost over the edge / At the sudden veering, the moment of turning.”
Do antidepressants enhance immune function?
Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most recent estimates, released in November 2007, by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), an estimated 33.2 million worldwide are living with HIV infection currently. Although the rates of infection appear to be decreasing, there are obviously immense implications for achieving improvements in HIV/AIDS treatment.
Proton-powered pooping
Muscles usually contract when a neurotransmitter molecule is released from nerve cells onto muscle cells. But University of Utah scientists discovered that bare subatomic protons can act like larger, more complex neurotransmitters, making gut muscles contract in tiny round worms so the worms can poop.
Some antipsychotic drugs may be missing their mark
Drugs that treat depression, schizophrenia and other psychotic conditions and that target a particular protein on brain cells might not be triggering the most appropriate response in those cells, new research suggests.
Human genetic variation -- Science's 'Breakthrough of the Year'
In 2007, researchers were dazzled by the degree to which genomes differ from one human to another and began to understand the role of these variations in disease and personal traits.
Science and its publisher, AAAS, the nonprofit science society, recognize “Human Genetic Variation” as the Breakthrough of the Year, and identify nine other of the year’s most significant scientific accomplishments in the 21 December issue.
Low dose of serotonin-acting chemical improves blood sugar tolerance
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of
Cell Metabolism, a publication of Cell Press. Importantly, the researchers found, those effects of the drug occurred at a low dose that had no influence on feeding behavior, body weight, activity level, or energy expenditure.
Proteins necessary for brain development found to be critical for long-term memory
A type of protein crucial for the growth of brain cells during development appears to be equally important for the formation of long-term memories, according to researchers at UC Irvine. The findings could lead to a better understanding of, and treatments for, cognitive decline associated with normal aging and diseases such as Alzheimer's.
Calcium may be the key to understanding Alzheimer's disease
Researchers at the University of Pennsylvania School of Medicine have shown that mutations in two proteins associated with familial Alzheimer's disease disrupt the flow of calcium ions within neurons. The two proteins, called PS1 and PS2 (presenilin 1 and 2), interact with a calcium release channel in an intracellular cell compartment.